Influenza A (H1N1) virus pneumonia in intensive care unit

Tuberkuloz ve Toraks

Volumn 58, Issue 3, 2010, Pages 278-285

  Adigüzel, Nalan ^a   Karakurt, Zuhal ^a   Kalamanoǧlu Balci, Merih ^a   Acartürk, Eylem ^a   Güngör, Gökay ^a   Yazicioǧlu Moçin, Özlem ^a   Bati Kutlu, Semra ^a   Yilmaz, Adnan ^a  

^a Research Hospital   (Turkey)

Author keywords

H1N1 virus infection; Intensive care unit

Indexed keywords

ALANINE AMINOTRANSFERASE; AMANTADINE; ASPARTATE AMINOTRANSFERASE; BETA LACTAM; C REACTIVE PROTEIN; HYPERTENSIVE AGENT; LINEZOLID; MOXIFLOXACIN; OSELTAMIVIR; OXYGEN; PERAMIVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIMANTADINE; TEICOPLANIN; ZANAMIVIR;

ACUTE RESPIRATORY FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APACHE; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL INFECTION; BLOOD OXYGEN TENSION; CASE STUDY; CLINICAL ARTICLE; DATA ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; EPIDEMIOLOGY; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; MALE; MEDICAL EDUCATION; MORTALITY; NASOGASTRIC TUBE; OBESITY; ORGAN INJURY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STUDY DESIGN; TURKEY (REPUBLIC); UNSPECIFIED SIDE EFFECT; VIRUS PNEUMONIA;

ADULT; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RESPIRATION, ARTIFICIAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TURKEY; YOUNG ADULT;

EID: 77958095291     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pérez-Padilla R, de la Rosa-Zamboni D, Ponce de León S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-9.
2. Centers for Disease Control and Prevention (CDC): hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009. MMWR 2009; 58: 536-41.
3. Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009; 13: R148.
4. The ANZIC Influenza Investigators. Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925-34.
5. Conti G, Larrsson A, Nava S, et al. On the role of non-invasive ventilation (NIV) to treat patients during the H1N1 influenza pandemic (http://dev.ersnet.org/uploads/Document/63/WEB-CHEMIN-5410-1258624143.pdf).
6. Hui DS, Chow BK, Ng SS et al. Exhaled air dispersion distances during noninvasive ventilation via different respironics face masks. Chest 2009; 136: 998-1005.
7. Hui DS, Hall SD, Chan MT, et al. Noninasive positive-pressure ventilation: an experimental model to assess air and particle dispersion. Chest 2006; 130: 730-40.
8. CDC protocol of realtime RT PCR for influenza A (H1N1). Geneva: World Health Organization, April 2009 (http://www.who.int/csr/resources/publications/ swineflu/CDCRealtimeRTPCR-SwineH1Assay-2009-20090430.pdf).
9. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
10. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-10. (Pubitemid 26254283)
11. T.C. Saǧlik Bakanliǧi 19.01.2010 tarihli aciklama (http://www.grip.gov.tr/index.php?option=com-content&view=article&id= 853:19012010-tarihli-acklama-sa-at-1800- &catid=113:basin- duyurulari&Itemid=540).
12. Centers for Disease Control and Prevention. Novel H1N1 flu: background on the situation (http://www.cdc.gov/h1n1flu/background.Htm).
13. Agarwal PP, Cinti S, Kazerooni E. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR 2009; 193: 1488-93.
14. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Atlanta: Centers for Disease Control and Prevention, 2009 (http://www.cdc.gov/H1N1flu/ recommendations.htm).
15. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva: World Health Organization, 2009 (http://www.who.int/csr/resources/publications/swineflu/h1n1-guidelines- pharmaceutical-mngt.pdf)
16. Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec 2009; 84: 453-9.
17. Centers for Disease Control and Prevention (CDC): oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR 2009; 58: 893-6.
18. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-44.
19. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-7.
20. Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003-32.
21. Centers for Disease Control and Prevention (CDC). Intensive care patients with severe novel influenza A (H1N1) virus infection-Michigan, June 2009. MMWR 2009; 58: 749-52.